Ameriprise
CTSO icon

Ameriprise’s Cytosorbents Corp CTSO Stock Holding History

Ameriprise’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,082
Closed -$222K – 3967
2022
Q2 		$222K Sell
5,082
-55
-1% -$2.53K ﹤0.01% 3660
2022
Q1 		$327K Buy
5,137
+116
+2% +$8.31K ﹤0.01% 3614
2021
Q4 		$421K Buy
5,021
+2,197
+78% +$247K ﹤0.01% 3572
2021
Q3 		$459K Sell
2,824
-1,172
-29% -$190K ﹤0.01% 3432
2021
Q2 		$604K Sell
3,996
-106
-3% -$17.9K ﹤0.01% 3389
2021
Q1 		$712K Buy
4,102
+2,192
+115% +$418K ﹤0.01% 3280
2020
Q4 		$305K Buy
+1,910
New +$320K ﹤0.01% 3499

Other funds holding CTSO

Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Redmile Group
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Ameriprise's CTSO Position: Q3 2022 in Review

Ameriprise sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 5,082 shares — an estimated $222K sold.

Ameriprise first reported a position in CTSO in Q4 2020 and held it in 7 quarters. The position peaked at $712K in Q1 2021. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Ameriprise reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Ameriprise sold 5,082 Cytosorbents Corp shares in Q3 2022, an estimated $222K.
  • Ameriprise first reported a position in Cytosorbents Corp in Q4 2020 and held it in 7 quarters.
  • Ameriprise's Cytosorbents Corp position peaked at $712K in Q1 2021.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Ameriprise's 13F filing for Q3 2022, filed 14 Nov 2022.